GMV The Future, page-2383

Hi M4L

Nice to see you back. Can't blame you for MIA given some of the conversations on this thread.

Whilst you generally have been spot on with your predictions and it's fair to say most investors in GMV understand the business model by now.

Problem is the market has completely given up on Yacov, the company, the products etc etc. Continual time blow outs, little follow up from the company on previous announcements, general lack of execution and no credibility left in the bank. I wonder how those new instos and HNW investors are feeling now? The only saving grace is volumes have picked up.

So what I have learnt today is the Nasdaq listing will be again delayed until 2021, which given the current state of the company and share price is just simply impossible at the moment.

The company is leasing the prizma, not selling it. I seriously find it very difficult to understand the revenue model, not to mention the reimbursement side of things.

Why does the company need to wait for NMPA approvals before it can embark on its global ambitions? It already has the infrastructure in the US to develop a very large business in its own right. Furthermore, Livecare and Meditel already have similar IDTF infrastructure in place which the prizma is to tap into.

Further to my previous investigations, I understand that GMV has sent Meditel more than one shipment of prizmas, how many I have no idea. Either way it shows they are moving product and the online store should be active this weekend. Lease or sell I really don't care. Not sure if any revenue will show up in the June 4c. Even an extra $100k would be better than nothing. Livecare in the US is probably the companies most promising distributor at the moment, but Livecare is yet to integrate the prizma into the Link+ platform. I can't get much info out of All Home Country Care, but they aren't marketing the prizma yet and can't really tell me much about it. Although they have what looks like a quality operations, im just not sure what they are waiting for.

I understand the company has had some manufacturing issues, but these seem to be largely fixed now, as evident by the supply into Meditel and the GMV online store.

I also understand that the data lodgement for the prizma NMPA application still has not occurred? This will blow out the approval process yet again?

How is the US IDTF business tracking? Particularly how yacov and the company stated in January it should grow at a similar 90% again this calendar year. If not the company should withdraw this guidance.

How is the company progressing with the hospital network in Ohio and Texas as touted the in December announcement...

And the patch, has a solitary one unit been deployed to a hospital in the US? Why the need for 2 manufacturing facilities in Israel to ramp up production? Is the company making thousands of these....where are they all going?

After what has been a very exciting and company making 6 months of approvals and distribution agreements, the runway is there and company just needs to execute. No more BS excuses.